Détails du rapport Vaer
Âge: 1 ans
Genre: Male
Région : Outside US
- Patient décédé?
- Non
- Renseignements sur les vaccins
-
Nom: MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)
Type : Measles, mumps, rubella and varicella vaccine live
Fabricant: MERCK & CO
Lot: u025964
- Date de réception du rapport
- 2022-03-04
- Date à laquelle le formulaire est complèté
- Date de vaccination
- 2022-01-19
- Date d’apparition
- 7
- Nombre de jours (date d’apparition – date de vaccination)
- 7
- Description de l’événement indésirable
-
fever greater than equals to 39.5; information has been downloaded from the regulatory authority (it-minisal02-844729). this spontaneous report was received from a other healthcare professional referring to a 1-year-old male patient. the patient's current conditions, medical history, concomitant medications and drug reactions/allergies were not reported. on 19-jan-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (rha) (proquad), via subcutaneous route in the left deltoid (lot # u025964 has been verified to be a valid lot number and expiration date was not reported but upon internal validation was established as 31-jan-2023) (dose, strength, indication and formulation were not reported). on 26-jan-2022, the patient experienced hyperpyrexia (reported as "fever greater than equals to 39.5 (units not provided)"). on 29-jan-2022, the patient recovered from hyperpyrexia. the causality assessment was not provided. the agency considered the event "hyperpyrexia" to be medically significant
- Données de laboratoire
-
na
- Liste des symptômes
-
hyperpyrexia
- Patient décédé?
- Non
- Date de décès
- N/A
- Anomalie congénitale
- false
- Vaccin administré par :
- Unknown
- Vaccin acheté par :
- Inconnu
- Visite d’un patient à l’urgence?
- Non
- Patient hospitalisé?
- Non
- Séjour à l’hôpital
- Non
- Nombre de jours à l’hôpital
- Non spécifié
- Invalidité permanente?
- Non
- Allergies:
-
na
- Maladie actuelle
-
na